|
|
 |
|
Viewing report
|
|
|
|
A Guide to Business & Regulatory Strategies: Companion Diagnostic Products and Individual Therapies
Drug and Market Development Publishing, June 2006, Pages: 155
A Guide to Business and Regulatory Strategies: Companion Diagnostic Products and Individual Therapies is a unique compilation of historical companion diagnostic products, business models for drug/diagnostic collaborations, education & marketing, intellectual property, regulatory, and reimbursement information for those interested in developing companion diagnostics, as well as stand-alone diagnostics.
The purpose of this report is to cover topics such as personalized medicine, existing products, business models, intellectual property, regulatory, and insurance/reimbursement issues intended to educate and advise the reader.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Key Trends In Drug-diagnostic Co-Development: Identifying Collaborative Opportunities and Navigating Regulatory Challenges
Companion Biomarkers in Drug Development
Companion Diagnostics in Personalized Medicine and Cancer Therapy
How Overcoming the Challenge of Biomarker Validation Can Pay Off for Drug and Diagnostic Developers
U.S. DNA-Based Diagnostic and Test Market
Disruption or Advantage? Update on Companion Diagnostics
Personalized Medicine - Scientific and Commercial Aspects
Cancer Personalized Medicine 2008
U.S. DNA-Based Diagnostic and Test Market
Trends in the Commercialization of Biomarkers: Tests and Companies
Personalized Medicine
Assay Development and Technologies, 2nd Edition
|
|
|
|
